This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, V.
Right arrow Articles by De Boer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, V.
Right arrow Articles by De Boer, R. J.

 Previous Article  |  Next Article 

Journal of Virology, March 2001, p. 2597-2603, Vol. 75, No. 6
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.6.2597-2603.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Release of Virus from Lymphoid Tissue Affects Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Kinetics in the Blood

Viktor Müller,1,* Athanasius F. M. Marée,2 and Rob J. De Boer2

Collegium Budapest, Institute for Advanced Study, 1014 Budapest, Hungary,1 and Theoretical Biology, Utrecht University, 3584 CH Utrecht, The Netherlands2

Received 19 July 2000/Accepted 20 December 2000

Kinetic parameters of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) infections have been estimated from plasma virus levels following perturbation of the chronically infected (quasi-) steady state. We extend previous models by also considering the large pool of virus localized in the lymphoid tissue (LT) compartment. The results indicate that the fastest time scale of HIV-1 plasma load decay during therapy probably reflects the clearance rate of LT virus and not, as previously supposed, the clearance rate of virus in plasma. This resolves the discrepancy between the clearance rate estimates during therapy and those based on plasma apheresis experiments. In the extended models plasma apheresis measurements are indeed expected to reflect the plasma decay rate. We can reconcile all current HIV-1 estimates with this model when, on average, the clearance rate of virus in plasma is approximately 20 day-1, that of LT virus is approximately 3 day-1, and the death rate of virus-producing cells is approximately 0.5 day-1. The fast clearance in the LT compartment increases current estimates for total daily virus production. Because HCV is produced in the liver, we let virus be produced into the blood compartment of our model. The results suggest that extending current HCV models with an LT compartment is not likely to affect current estimates for kinetic parameters and virus production. Estimates for treatment efficacy might be affected, however.


* Corresponding author. Mailing address: Collegium Budapest, Institute for Advanced Study, Szentháromság u. 2, 1014 Budapest, Hungary. Phone: 36 1 224 8306. Fax: 36 1 224 8310. E-mail: muller_v{at}ludens.elte.hu.


Journal of Virology, March 2001, p. 2597-2603, Vol. 75, No. 6
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.6.2597-2603.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Keele, B. F., Tazi, L., Gartner, S., Liu, Y., Burgon, T. B., Estes, J. D., Thacker, T. C., Crandall, K. A., McArthur, J. C., Burton, G. F. (2008). Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1. J. Virol. 82: 5548-5561 [Abstract] [Full Text]  
  • Graziano, F. M., Kettoola, S. Y., Munshower, J. M., Stapleton, J. T., Towfic, G. J. (2008). Effect of spatial distribution of T-Cells and HIV load on HIV progression. Bioinformatics 24: 855-860 [Abstract] [Full Text]  
  • Roque-Afonso, A.-M., Ducoulombier, D., Di Liberto, G., Kara, R., Gigou, M., Dussaix, E., Samuel, D., Feray, C. (2005). Compartmentalization of Hepatitis C Virus Genotypes between Plasma and Peripheral Blood Mononuclear Cells. J. Virol. 79: 6349-6357 [Abstract] [Full Text]  
  • Muller, V., Vigueras-Gomez, J. F., Bonhoeffer, S. (2002). Decelerating Decay of Latently Infected Cells during Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection. J. Virol. 76: 8963-8965 [Abstract] [Full Text]  
  • Maggi, F., Pistello, M., Vatteroni, M., Presciuttini, S., Marchi, S., Isola, P., Fornai, C., Fagnani, S., Andreoli, E., Antonelli, G., Bendinelli, M. (2001). Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection. J. Virol. 75: 11999-12004 [Abstract] [Full Text]